D. E. Shaw & Co., Inc. Molecular Templates, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $116,472 - $158,386	-20,151 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $49,234 - $78,322	6,296 Added 45.44%	20,151 $158,000
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $151,976 - $228,860	-16,289 Reduced 54.04%	13,855 $175,000
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $12,711 - $18,332	1,499 Added 5.23%	30,144 $283,000
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $286,163 - $412,774	28,645 New	28,645 $313,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.